Kerem Çil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kerem Çil has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Barış Kayaalp
Bilkent University
4 shared publications - Tayfun Ozcelik
Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
4 shared publications - Aurélie Cobat
Necker Branch, INSERM UMR 1163 3 Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, Université Paris Cité Paris
2 shared publications Clément Conil
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France
2 shared publicationsJean-Laurent Casanova
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France
2 shared publications- Meltem Ece Kars
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
2 shared publications
Latest Publications
- Open Access
Gene-based map of cardiovascular diseases
Background: Rare coding variants contribute to cardiovascular disease, but their effects across disease groups remain incompletely characterized. In particular, the influence of functionally and clinically informed variant classification and sex-specific genetic effects on gene–phenotype associations remains understudied. Methods: We analyzed whole-genome sequencing data from up to 483,311 UK Biobank participants across six genetic ancestry groups and eight cardiovascular phenotype groups. Gene-burden testing integrated state-of-the-art missense classification and predicted pathogenic germline variants. We performed combined-sex and sex-stratified analyses, followed by cross-ancestry meta-analysis. We additionally adjusted for cardiometabolic traits in sensitivity analyses, estimated penetrance among qualifying-variant carriers, and assessed genetic prevalence across eight ancestry groups. Results: We identified 86 exome-wide significant gene–phenotype associations: 40 established and 46 novel. Novel associations included EHMT2 with atrial fibrillation, P2RX1 with arrhythmias, P2RY4 with complete atrioventricular block, and NOSTRIN with atherosclerotic heart disease in females. After cardiometabolic adjustment, 60 associations retained exome-wide significance and 18 additional associations emerged, including CDH11 , PARVA , and ADAMDEC1 with atherosclerosis-related phenotypes. Conclusions: These findings identify novel cardiovascular gene–phenotype associations implicating purinergic signaling, endothelial nitric oxide regulation, and vascular wall biology. Variant selection shapes penetrance estimates and the interpretation of inherited susceptibility.
Open AccessGene-based map of cardiovascular diseases
Background: Rare coding variants contribute to cardiovascular disease, but their effects across disease groups remain incompletely characterized. In particular, the influence of functionally and clinically informed variant classification and sex-specific genetic effects on gene–phenotype associations remains understudied. Methods: We analyzed whole-genome sequencing data from up to 483,311 UK Biobank participants across six genetic ancestry groups and eight cardiovascular phenotype groups. Gene-burden testing integrated state-of-the-art missense classification and predicted pathogenic germline variants. We performed combined-sex and sex-stratified analyses, followed by cross-ancestry meta-analysis. We additionally adjusted for cardiometabolic traits in sensitivity analyses, estimated penetrance among qualifying-variant carriers, and assessed genetic prevalence across eight ancestry groups. Results: We identified 86 exome-wide significant gene–phenotype associations: 40 established and 46 novel. Novel associations included EHMT2 with atrial fibrillation, P2RX1 with arrhythmias, P2RY4 with complete atrioventricular block, and NOSTRIN with atherosclerotic heart disease in females. After cardiometabolic adjustment, 60 associations retained exome-wide significance and 18 additional associations emerged, including CDH11 , PARVA , and ADAMDEC1 with atherosclerosis-related phenotypes. Conclusions: These findings identify novel cardiovascular gene–phenotype associations implicating purinergic signaling, endothelial nitric oxide regulation, and vascular wall biology. Variant selection shapes penetrance estimates and the interpretation of inherited susceptibility.
- 26 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2350-2360
Prediction of human missense variant effects from functional evidence
- 26 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2350-2360
Prediction of human missense variant effects from functional evidence
- Open Access
- 16 July 2026
- Published by Springer Nature in Research Square
Gene-based map of cardiometabolic diseases
Cardiometabolic disorders are common, interrelated conditions with substantial genetic contribution. We performed sex- and ancestry-stratified rare-variant gene-burden analyses in UK Biobank across obesity, fatty liver disease, dyslipidemia, hypertension, chronic kidney disease, and diabetes mellitus, with Turkish Variome contributing to obesity analyses, using state-of-the-art variant classification tools. This approach replicated established gene–phenotype relationships and expanded the number of causal cardiometabolic gene–phenotype associations from 368 to 534. Complementary genetic-epidemiological analyses showed that approximately one in six individuals carries risk-increasing alleles and one in nine carries protective alleles.
- 16 July 2026
- Published by Springer Nature in Research Square
Open AccessGene-based map of cardiometabolic diseases
Cardiometabolic disorders are common, interrelated conditions with substantial genetic contribution. We performed sex- and ancestry-stratified rare-variant gene-burden analyses in UK Biobank across obesity, fatty liver disease, dyslipidemia, hypertension, chronic kidney disease, and diabetes mellitus, with Turkish Variome contributing to obesity analyses, using state-of-the-art variant classification tools. This approach replicated established gene–phenotype relationships and expanded the number of causal cardiometabolic gene–phenotype associations from 368 to 534. Complementary genetic-epidemiological analyses showed that approximately one in six individuals carries risk-increasing alleles and one in nine carries protective alleles.
- Open Access
- 3 October 2025
- Published by Springer Nature in Research Square
Prediction of human missense variant effects from functional evidence
Prediction of missense variant effects remains the critical bottleneck in disease gene identification and clinical interpretation. Current predictors rely on clinical outcomes or population patterns, rather than direct measures of functional impact, leading to limited generalizability and data circularity. We present FuncVEP, the first family of variant effect predictors trained exclusively on balanced and diverse functional data, providing a direct representation of functional effect. FuncVEP generalizes across contexts, outperforming 47 existing predictors on both clinical and functional benchmarks, improving the accuracy from 82% to 93% and reducing uncertain classifications from 11% to 2%. To illustrate its utility in gene discovery, we applied FuncVEP to 490 inborn errors of immunity genes in the UK Biobank and Mount Sinai Million Health Discoveries Program, identifying 50 novel gene–phenotype associations. FuncVEP provides a robust, scalable solution for variant interpretation, advancing both diagnostic precision and gene discovery.
- 3 October 2025
- Published by Springer Nature in Research Square
Open AccessPrediction of human missense variant effects from functional evidence
Prediction of missense variant effects remains the critical bottleneck in disease gene identification and clinical interpretation. Current predictors rely on clinical outcomes or population patterns, rather than direct measures of functional impact, leading to limited generalizability and data circularity. We present FuncVEP, the first family of variant effect predictors trained exclusively on balanced and diverse functional data, providing a direct representation of functional effect. FuncVEP generalizes across contexts, outperforming 47 existing predictors on both clinical and functional benchmarks, improving the accuracy from 82% to 93% and reducing uncertain classifications from 11% to 2%. To illustrate its utility in gene discovery, we applied FuncVEP to 490 inborn errors of immunity genes in the UK Biobank and Mount Sinai Million Health Discoveries Program, identifying 50 novel gene–phenotype associations. FuncVEP provides a robust, scalable solution for variant interpretation, advancing both diagnostic precision and gene discovery.